Investigational Site Number 410006

Seoul 152-703

0 studies enrolling now · 6 studies all time

What they study most

Asthma, Atherosclerotic Cardiovascular Disease, Cancer, Hematopoietic Neoplasm, Rheumatoid Arthritis, Venous Thromboembolism

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed